Search

everythinglearnresearchcommunity

for

Search:↓

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Current treatments for alopecia show no significant long-term benefits.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Atopic dermatitis is common in developing countries, but many patients receive poor care due to inconsistent guidelines and lack of resources.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Tinea incognito in Iran commonly affects adults and mimics other skin conditions.

Facial rejuvenation surgery has evolved to yield natural results with low complication rates, and more men and older patients are choosing this surgery.

Treat scalp and beard fungal infections early with oral antifungal medication and sometimes topical therapy, avoiding unnecessary allergy tests and surgery.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.